- Home
- DTST vs OCX Comparison
DTST vs OCX Comparison
Compare DTST & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- OCX
- Stock Information
- Founded
- DTST 2001
- OCX 2009
- Country
- DTST United States
- OCX United States
- Employees
- DTST N/A
- OCX N/A
- Industry
- DTST EDP Services
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DTST Technology
- OCX Health Care
- Exchange
- DTST Nasdaq
- OCX Nasdaq
- Market Cap
- DTST 32.7M
- OCX 80.1M
- IPO Year
- DTST N/A
- OCX N/A
- Fundamental
- Price
- DTST $3.41
- OCX $3.55
- Analyst Decision
- DTST
- OCX Buy
- Analyst Count
- DTST 0
- OCX 3
- Target Price
- DTST N/A
- OCX $4.42
- AVG Volume (30 Days)
- DTST 36.7K
- OCX 126.9K
- Earning Date
- DTST 03-27-2025
- OCX 04-11-2025
- Dividend Yield
- DTST N/A
- OCX N/A
- EPS Growth
- DTST N/A
- OCX N/A
- EPS
- DTST 0.02
- OCX N/A
- Revenue
- DTST $25,143,911.00
- OCX $709,000.00
- Revenue This Year
- DTST $2.57
- OCX N/A
- Revenue Next Year
- DTST $11.16
- OCX $106.34
- P/E Ratio
- DTST $173.36
- OCX N/A
- Revenue Growth
- DTST 1.64
- OCX N/A
- 52 Week Low
- DTST $3.24
- OCX $1.92
- 52 Week High
- DTST $8.00
- OCX $4.75
- Technical
- Relative Strength Index (RSI)
- DTST 38.21
- OCX 61.92
- Support Level
- DTST $3.40
- OCX $3.44
- Resistance Level
- DTST $3.64
- OCX $4.75
- Average True Range (ATR)
- DTST 0.21
- OCX 0.44
- MACD
- DTST -0.02
- OCX 0.07
- Stochastic Oscillator
- DTST 23.44
- OCX 49.36
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.